\-\ Texto\\:\\ \ \(0\)\
\-\ unremarkable\\ physical\\ exam\\ and\\ labs\\.\ \(0\)\
\-\ this\\ patient\\ will\\ be\\ conservatively\\ managed\\ by\\ follow\\-up\\ imaging\\ only\\.\ \(0\)\
\-\ axial\\ pre\\-contrast\\ ct\\ image\\ demonstrates\\ a\\ large\\ heterogeneous\\-appearing\\ lesion\\ in\\ the\\ deep\\ white\\ matter\\/basal\\ ganglia\\ of\\ left\\ frontal\\ region\\.\\ the\\ lesion\\ demonstrates\\ high\\ density\\ resulting\\ from\\ calcification\\ and\\/or\\ small\\ areas\\ of\\ hemorrhage\\.\\ \ \(0\)\
\-\ t2\\-weighted\\ mri\\ demonstrates\\ a\\ hypointense\\ blooming\\ artifact\\ within\\ a\\ lesion\\ in\\ the\\ left\\ frontal\\ lobe\\.\ \(0\)\
\-\ gradient\\-echo\\ mri\\ demonstrates\\ multiple\\,\\ bilateral\\ punctate\\ and\\ rounded\\ areas\\ of\\ hypointensity\\ within\\ the\\ periventricular\\ and\\ subcortical\\ white\\ matter\\.\ \(0\)\
\-\ cerebral\\ cavernous\\ malformation\\ \\(angioma\\)\ \(0\)\
\-\ \\â\\€\\¢cerebral\\ cavernous\\ malformation\ \(0\)\
\-\ \\â\\€\\¢other\\ occult\\ vascular\\ malformation\\ \\(thrombosed\\ avm\\/aneurysm\\,\\ capillary\\ telangiectasia\\)\ \(0\)\
\-\ \\â\\€\\¢hemorrhagic\\ primary\\ or\\ secondary\\ neoplasm\\ \\(metastatic\\ melanoma\\,\\ thyroid\\,\\ renal\\ cell\\,\\ choriocarcinoma\\)\ \(0\)\
\-\ \\â\\€\\¢amyloid\\ angiopathy\ \(0\)\
\-\ \\â\\€\\¢treated\\ or\\ prior\\ infection\\ \\(toxoplasmosis\\,\\ cysticercosis\\)\ \(0\)\
\-\ \\â\\€\\¢multiple\\ hemorrhages\\ associated\\ with\\ blood\\ dyscrasia\\ \\(disseminated\\ intravascular\\ coagulopathy\\,\\ leukemia\\)\ \(0\)\
\-\ 34\\ year\\ old\\ man\\ with\\ history\\ of\\ intermittent\\ headaches\\ throughout\\ the\\ last\\ 10\\ years\\.\\ the\\ last\\ 4\\ episodes\\ were\\ associated\\ with\\ transient\\ minimal\\ non\\-specific\\ neurological\\ deficits\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ malformation\\:\\ 0\\.05842879975725222\ \(0\)\
\-\ heterogeneous\\-appearing\\:\\ 0\\.05037439099409428\ \(0\)\
\-\ matter\\/basal\\:\\ 0\\.05037439099409428\ \(0\)\
\-\ avm\\/aneurysm\\:\\ 0\\.05037439099409428\ \(0\)\
\-\ \\â\\€\\¢amyloid\\:\\ 0\\.05037439099409428\ \(0\)\
\-\ \\â\\€\\¢treated\\:\\ 0\\.05037439099409428\ \(0\)\
\-\ \\â\\€\\¢cerebral\\:\\ 0\\.04641354996232316\ \(0\)\
\-\ \\â\\€\\¢other\\:\\ 0\\.04641354996232316\ \(0\)\
\-\ dyscrasia\\:\\ 0\\.04641354996232316\ \(0\)\
\-\ cavernous\\:\\ 0\\.04529700754339293\ \(0\)\
\-\ gradient\\-echo\\:\\ 0\\.04409660648741936\ \(0\)\
\-\ \\â\\€\\¢hemorrhagic\\:\\ 0\\.04409660648741936\ \(0\)\
\-\ demonstrates\\:\\ 0\\.04266562746635854\ \(0\)\
\-\ last\\:\\ 0\\.04172265657191982\ \(0\)\
\-\ \\â\\€\\¢multiple\\:\\ 0\\.03925490442806391\ \(0\)\
\-\ blooming\\:\\ 0\\.037818821980744446\ \(0\)\
\-\ pre\\-contrast\\:\\ 0\\.03571753752288549\ \(0\)\
\-\ choriocarcinoma\\:\\ 0\\.03571753752288549\ \(0\)\
\-\ coagulopathy\\:\\ 0\\.03571753752288549\ \(0\)\
\-\ hemorrhages\\:\\ 0\\.03453102686700981\ \(0\)\
\-\ angiopathy\\:\\ 0\\.03418460045663018\ \(0\)\
\-\ thrombosed\\:\\ 0\\.03325592085950004\ \(0\)\
\-\ telangiectasia\\:\\ 0\\.032977119921389\ \(0\)\
\-\ intravascular\\:\\ 0\\.032977119921389\ \(0\)\
\-\ areas\\:\\ 0\\.03286111052852648\ \(0\)\
\-\ white\\:\\ 0\\.032389762430994486\ \(0\)\
\-\ toxoplasmosis\\:\\ 0\\.03133322236452168\ \(0\)\
\-\ hypointensity\\:\\ 0\\.030938977384596243\ \(0\)\
\-\ frontal\\:\\ 0\\.030677622108381226\ \(0\)\
\-\ cysticercosis\\:\\ 0\\.030394347785714388\ \(0\)\
\-\ lesion\\:\\ 0\\.029838089588579225\ \(0\)\
\-\ subcortical\\:\\ 0\\.029740574350412993\ \(0\)\
\-\ disseminated\\:\\ 0\\.029740574350412993\ \(0\)\
\-\ occult\\:\\ 0\\.029439753016210584\ \(0\)\
\-\ capillary\\:\\ 0\\.028750450228847067\ \(0\)\
\-\ angioma\\:\\ 0\\.028622033909692448\ \(0\)\
\-\ punctate\\:\\ 0\\.028496440157013733\ \(0\)\
\-\ non\\-specific\\:\\ 0\\.028253242360334902\ \(0\)\
\-\ periventricular\\:\\ 0\\.02813541786203355\ \(0\)\
\-\ conservatively\\:\\ 0\\.027171859505257596\ \(0\)\
\-\ transient\\:\\ 0\\.02643350675394327\ \(0\)\
\-\ managed\\:\\ 0\\.02626291839308795\ \(0\)\
\-\ artifact\\:\\ 0\\.025936298885431103\ \(0\)\
\-\ leukemia\\:\\ 0\\.025055437857846766\ \(0\)\
\-\ ganglia\\:\\ 0\\.024987812385578182\ \(0\)\
\-\ melanoma\\:\\ 0\\.024920977872645658\ \(0\)\
\-\ t2\\-weighted\\:\\ 0\\.02472504030991062\ \(0\)\
\-\ 34\\:\\ 0\\.024233185402646375\ \(0\)\
\-\ episodes\\:\\ 0\\.024116563279039476\ \(0\)\
\-\ rounded\\:\\ 0\\.024059132788448036\ \(0\)\
\-\ hypointense\\:\\ 0\\.02316196850953567\ \(0\)\
\-\ associated\\:\\ 0\\.023045286421802307\ \(0\)\
\-\ mri\\:\\ 0\\.02243743834188137\ \(0\)\
\-\ deficits\\:\\ 0\\.022344249403017536\ \(0\)\
\-\ resulting\\:\\ 0\\.021445276519654465\ \(0\)\
\-\ neurological\\:\\ 0\\.021128712065998534\ \(0\)\
\-\ intermittent\\:\\ 0\\.020960136840874544\ \(0\)\
\-\ \\(\\:\\ 0\\.0206389064641103\ \(0\)\
\-\ and\\/or\\:\\ 0\\.020637209925084016\ \(0\)\
\-\ \\)\\:\\ 0\\.020386791203237286\ \(0\)\
\-\ thyroid\\:\\ 0\\.020013213970998346\ \(0\)\
\-\ deep\\:\\ 0\\.01976532656739706\ \(0\)\
\-\ matter\\:\\ 0\\.019225599830861702\ \(0\)\
\-\ minimal\\:\\ 0\\.019225599830861702\ \(0\)\
\-\ headaches\\:\\ 0\\.01866538479469302\ \(0\)\
\-\ within\\:\\ 0\\.018630073238698076\ \(0\)\
\-\ throughout\\:\\ 0\\.018278556150285296\ \(0\)\
\-\ calcification\\:\\ 0\\.017724489248326453\ \(0\)\
\-\ labs\\:\\ 0\\.016982708611057933\ \(0\)\
\-\ cerebral\\:\\ 0\\.01691683715293755\ \(0\)\
\-\ neoplasm\\:\\ 0\\.01662946614806816\ \(0\)\
\-\ 10\\:\\ 0\\.01646070987626806\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.016252894766720205\ \(0\)\
\-\ unremarkable\\:\\ 0\\.016166093821040346\ \(0\)\
\-\ density\\:\\ 0\\.016066464896342624\ \(0\)\
\-\ vascular\\:\\ 0\\.01601030438813541\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.015885925665381384\ \(0\)\
\-\ will\\:\\ 0\\.015277034390737954\ \(0\)\
\-\ image\\:\\ 0\\.015252509521700576\ \(0\)\
\-\ only\\:\\ 0\\.014682352334199632\ \(0\)\
\-\ renal\\:\\ 0\\.01467128885404611\ \(0\)\
\-\ primary\\:\\ 0\\.01446505293083255\ \(0\)\
\-\ years\\:\\ 0\\.014338532211534185\ \(0\)\
\-\ infection\\:\\ 0\\.014194380423273183\ \(0\)\
\-\ axial\\:\\ 0\\.013935951291816408\ \(0\)\
\-\ region\\:\\ 0\\.013792007012796072\ \(0\)\
\-\ secondary\\:\\ 0\\.013651599808621757\ \(0\)\
\-\ 4\\:\\ 0\\.013605553743880259\ \(0\)\
\-\ high\\:\\ 0\\.013363120349010375\ \(0\)\
\-\ blood\\:\\ 0\\.013328063271481711\ \(0\)\
\-\ cell\\:\\ 0\\.013189946923322779\ \(0\)\
\-\ lobe\\:\\ 0\\.01313900198813448\ \(0\)\
\-\ prior\\:\\ 0\\.01253778726972779\ \(0\)\
\-\ metastatic\\:\\ 0\\.012292053734949087\ \(0\)\
\-\ physical\\:\\ 0\\.01198003011189279\ \(0\)\
\-\ bilateral\\:\\ 0\\.011850387024653965\ \(0\)\
\-\ man\\:\\ 0\\.01154818196051428\ \(0\)\
\-\ or\\:\\ 0\\.011445974273870943\ \(0\)\
\-\ imaging\\:\\ 0\\.011440421854032014\ \(0\)\
\-\ small\\:\\ 0\\.011249001625034963\ \(0\)\
\-\ were\\:\\ 0\\.011087350495370978\ \(0\)\
\-\ left\\:\\ 0\\.010926917363119026\ \(0\)\
\-\ \\,\\:\\ 0\\.010828402620691496\ \(0\)\
\-\ exam\\:\\ 0\\.010727051085425932\ \(0\)\
\-\ large\\:\\ 0\\.010677385324749027\ \(0\)\
\-\ multiple\\:\\ 0\\.01028460573416725\ \(0\)\
\-\ by\\:\\ 0\\.008130690875684998\ \(0\)\
\-\ be\\:\\ 0\\.007530038419108167\ \(0\)\
\-\ from\\:\\ 0\\.0072367755037383566\ \(0\)\
\-\ ct\\:\\ 0\\.006830306590811673\ \(0\)\
\-\ a\\:\\ 0\\.006798853745461736\ \(0\)\
\-\ history\\:\\ 0\\.006744083072611905\ \(0\)\
\-\ this\\:\\ 0\\.0054922126475093315\ \(0\)\
\-\ year\\:\\ 0\\.005463458681559513\ \(0\)\
\-\ old\\:\\ 0\\.004999626267784312\ \(0\)\
\-\ patient\\:\\ 0\\.004894811033807931\ \(0\)\
\-\ in\\:\\ 0\\.004815968344460056\ \(0\)\
\-\ the\\:\\ 0\\.004739975475552885\ \(0\)\
\-\ and\\:\\ 0\\.0030858686696951737\ \(0\)\
\-\ of\\:\\ 0\\.0026629440182397357\ \(0\)\
\-\ with\\:\\ 0\\.002005785875826681\ \(0\)\
\-\ \\.\\:\\ 0\\.0016228359358786868\ \(0\)\
